Informace o publikaci

Role of Plasma Neutrophil Gelatinase Associated Lipocalin as a New Biomarker

Autoři

HLINOMAZ Ota

Rok publikování 2016
Druh Článek v odborném periodiku
Časopis / Zdroj Journal of Critical Care Medicine
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Doi http://dx.doi.org/10.1515/jccm-2016-0004
Obor Kardiovaskulární nemoci včetně kardiochirurgie
Klíčová slova Plasma Neutrophil Gelatinase
Popis I read with interest the study of Raluca Fodor et al., on the significance of Plasma Neutrophil Gelatinase-Associated Lipocalin (NGAL), as an early biomarker for acute kidney injury in critically ill patients, published recently in issue no.4/2015 of JCCM journal [1]. In this well-written and interesting study, the authors successfully demonstrated that in critically ill patients, increased levels of NGAL predict, with a good sensitivity and specificity, the development of acute kidney injury within forty-eight hours of admission to an ICU. However, as no information is presented on the aetiology of the acute kidney injury, we believe that the article raises interesting and still un-elucidated hypotheses on the pathophysiological substrate of the systemic release of NGAL in patients with critical conditions.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info